Overview Impact of COX2 on Sera Biomarkers From Obese Subjects Status: Completed Trial end date: 2016-04-01 Target enrollment: Participant gender: Summary Obesity promotes worse outcome for post-menopausal breast cancer patients. Phase: Early Phase 1 Details Lead Sponsor: The University of Texas Health Science Center at San AntonioTreatments: Aspirin